KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Research & Development (2016 - 2025)

Historic Research & Development for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $3.7 billion.

  • Johnson & Johnson's Research & Development fell 2584.81% to $3.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 billion, marking a year-over-year decrease of 428.29%. This contributed to the annual value of $17.2 billion for FY2024, which is 1423.27% up from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's Research & Development is $3.7 billion, which was down 2584.81% from $3.5 billion recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Research & Development ranged from a high of $5.3 billion in Q4 2024 and a low of $3.2 billion during Q2 2021
  • Over the past 5 years, Johnson & Johnson's median Research & Development value was $3.5 billion (recorded in 2025), while the average stood at $3.8 billion.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 4366.12% in 2024, then crashed by 2584.81% in 2025.
  • Johnson & Johnson's Research & Development (Quarter) stood at $3.4 billion in 2021, then grew by 1.84% to $3.5 billion in 2022, then increased by 28.55% to $4.5 billion in 2023, then grew by 18.26% to $5.3 billion in 2024, then tumbled by 30.69% to $3.7 billion in 2025.
  • Its last three reported values are $3.7 billion in Q3 2025, $3.5 billion for Q2 2025, and $3.2 billion during Q1 2025.